Table 2. Asymmetric Bioreduction of β-Cyanoacrylic Esters Using Wild-Type and Mutant Variants of OPR1a.
Key: c. = conversion [%]; e.e. = enantiomeric excess of products 1b–5b [%]; n.c. = no conversion.
Key: c. = conversion [%]; e.e. = enantiomeric excess of products 1b–5b [%]; n.c. = no conversion.